Literature DB >> 28118159

Clear Cell Carcinoma of the Cervix With Choriocarcinomatous Differentiation: Report of an Extremely Rare Phenomenon Associated With Mismatch Repair Protein Abnormality.

Pinias Mukonoweshuro1, W Glenn McCluggage.   

Abstract

The presence of trophoblastic differentiation or nongestational choriocarcinoma in a carcinoma is rare but has been described in various organs, including in the female genital tract. We report a cervical clear cell carcinoma admixed with a component of choriocarcinoma in a 52-year-old woman, only the second report of this combination in the literature. Immunohistochemically, the tumor exhibited isolated loss of staining with the mismatch repair protein MSH6. We review the literature on trophoblastic differentiation in cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28118159     DOI: 10.1097/PGP.0000000000000328

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

Review 1.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

2.  Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation.

Authors:  Stephanie L Skala; Chia-Jen Liu; Aaron M Udager; Andrew P Sciallis
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

3.  New Insights in the Diagnosis of Rare Adenocarcinoma Variants of the Cervix-Case Report and Review of Literature.

Authors:  Cristina Secosan; Oana Balint; Aurora Ilian; Lavinia Balan; Ligia Balulescu; Andrei Motoc; Delia Zahoi; Dorin Grigoras; Laurentiu Pirtea
Journal:  Healthcare (Basel)       Date:  2022-07-28

4.  Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry.

Authors:  Meiping Li; Lei Bao; Bo Lu; Wenshun Ge; Lifang Ren
Journal:  Diagn Pathol       Date:  2022-10-13       Impact factor: 3.196

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.